VP, Health Economics and Access Strategy
HeartFlowSalary not specified
- Full Time
- Senior (5 to 8 years)
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, HealthcareIndustries
Requirements
Candidates should possess a Master’s Degree and 10+ years of experience, or a Bachelor’s Degree and 12+ years of experience. They require an extensive understanding of the transplant clinical landscape and the business of cell therapy, along with excellent strategic thinking skills to formulate and execute market access strategies based on analytical skills. Proven experience in developing market access strategy/materials and marketing initiatives for oncology products is also necessary.
Responsibilities
The Director, U.S. Value, Access, & Pricing Strategy will lead the Orca-T U.S. Market Access Strategy, collaborating with field market access directors to execute reimbursement and access strategies. This includes developing strategic plans, creating value proposition tools, and managing payer and provider relationships. The role involves delivering value evidence packages, defining evolving Orca-T value in the market, collaborating with HEOR, and contributing to pricing & contracting strategies. Additionally, the Director will conduct market research, collect insights regarding customer experience, and contribute to policy/government affairs advocacy, ensuring all activities adhere to regulatory and legal requirements.
Skills
Market Access Strategy
Reimbursement Strategy
Healthcare Policy
Cross-functional Collaboration
Biotechnology
Cell Therapy
Healthcare Economics
Stakeholder Engagement
Regulatory Environment
Orca Bio
Develops and commercializes cell therapies
About Orca Bio
Orca Bio operates in the biotechnology sector, specifically focusing on cell therapies that utilize the body's own cells to treat diseases. The company works to enhance these therapies, aiming to make them safer and more effective for patients. Orca Bio's products are primarily used by healthcare providers who administer these therapies to patients as part of their treatment plans. Unlike many competitors, Orca Bio emphasizes a strong team culture and values communication with stakeholders, keeping them informed about the company's progress and developments. The goal of Orca Bio is to improve patient outcomes through advanced cell therapies, addressing conditions that currently have limited treatment options.
Key Metrics
Menlo Park, CaliforniaHeadquarters
2016Year Founded
$186.8MTotal Funding
SERIES_DCompany Stage
Biotechnology, HealthcareIndustries
51-200Employees